The last paragraph from the sensitive announcement some 4 months ago.
"Bill Mobbs, ITL Health Group Executive Chairman, commented “These products show ITL BioMedical is hitting the milestones required to expand its presence in the global blood culture testing market.” “Since the sale of our Custom Pack business last October ITL has invested a large amount in sales and marketing which means we are well placed to monetise the chain of new products to come in 2018.”
Some promising big words from B Moss, yet SP falls like an accelerating knife, Managment sold shares at high levels. so did many of us shareholders.
Wouldnt you think that if the picture is rosy, Managment would jump on board and scoop shares from the ground at such low level . they sold at 47 c buying at 20 c surely is a bargain. or MAYBE NOT ?
I got back at 25 c thinking its a steal, apparently not, keeps on sliding.
Can someone knock on the office/ factory/ lab doors, just to make sure there's someone in there
ITD Price at posting:
20.0¢ Sentiment: None Disclosure: Held